New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 4, 2014
06:14 EDTRGLSRegulus Therapeutics files $100M mixed shelf, 7.9M shares of stock for holders
News For RGLS From The Last 14 Days
Check below for free stories on RGLS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
July 21, 2014
08:18 EDTRGLSRegulus Therapeutics granted orphan drug designation for RG-012 by FDA
Regulus Therapeutics announced that the FDA has granted orphan drug designation to RG-012, a single stranded, chemically modified oligonucleotide that binds to and inhibits the function of microRNA-21, as a therapeutic for the treatment of Alport syndrome, a life-threatening genetic kidney disease with no approved therapy. In the near term, Regulus expects to initiate a natural history of disease study to gather further information about the progression of Alport syndrome and to inform future clinical development plans of RG-012, a key program under Regulus' 'Clinical Map Initiative'.
July 18, 2014
15:04 EDTRGLSWedbush reiterates Outperform rating on Regulus after orphan designation
Subscribe for More Information
11:05 EDTRGLSRegulus Therapeutics treatment of Alport syndrome designated as orphan drug
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use